510(k) device
MiniMed Connect kit
Medtronic Minimed, Inc. · Continuous Glucose Monitor Secondary Display (PJT, Class II) · First FDA decision May 19, 2015, newest May 19, 2015Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "MiniMed Connect"
MAUDE reports
1
Brand "MiniMed Connect", since 2015
PubMed studies
0
Mentioning "MiniMed Connect"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MiniMed Connect kit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K151236 · Decided May 19, 2015 · 8 days after receipt
Device type: Continuous Glucose Monitor Secondary Display (PJT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38662CGS Administrators, LLCUpdated Sep 29, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38623Wellpoint FederalUpdated Jul 14, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38686WPS Insurance CorporationUpdated Jun 18, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38657Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38743Palmetto GBAUpdated Jul 19, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38664First Coast Service Options, Inc.Updated Jun 21, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38617Novitas Solutions, Inc.Updated Jun 21, 2024
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "MiniMed Connect", any status and sponsor, newest update first.
Kinderkrankenhaus auf der BultAcademic, hospital or other
NCT02636491 · 45 participants · Start Dec 2015 · Primary completion Jun 2016
Device: MD-Logic-Automated Insulin Delivery System; MiniMed Paradigm® Veo™ System · For: Type 1 Diabetes
Sites: Hanover, Germany
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MiniMed Connect", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code PJT
61 reports: 45 malfunction, 15 injury, 0 death
Newest reports for this brand
- MINIMED CONNECTMalfunction
MW5064352 · Received Aug 23, 2016 · Event dated Aug 20, 2016
Device type: Continuous Glucose Monitor Secondary Display (PJT)
Device problem as coded: Device Alarm System; Application Program Problem; Computer Operating System Problem
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0843-2021 · Started Nov 12, 2020
Reason given: Incomplete basal rate information may be transmitted leading to a potential for inappropriate change in therapy. During data upload, radio frequency (RF) interference can occur at any point from surrounding devices or equipment that may affect the data transfer between the insulin pump and the CareLink Personal or...
Cause as FDA categorized it: Device Design · Device type: Sensor, Glucose, Invasive (MDS)
Published research
The most relevant PubMed records for "MiniMed Connect"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PJT.
- Dexcom Share Direct Secondary DisplaysDexcom, Inc. · De Novo 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.